aap Implantate announces capital increase via rights issue and debt-to-equity swap

aap Implantate AG's Management Board, with Supervisory Board approval, announced a capital increase against cash contributions via a rights issue of up to 1,486,563 new shares at EUR 1.35 each, with a 9.9-to-1 subscription ratio and a subscription period expected from November 6 to 20, 2026. The company also confirmed its full-year 2026 revenue and EBITDA guidance.

Detected & updated continuously · Source: Nebula